News

How vitamin D reduces liver damage by boosting TXNIP activity in bile duct cells
Chronic liver disease (CLD) is a major global health concern, affecting approximately 1.5 billion people. This ...
Medscape9h
Alcohol-Related Liver Disease Increases Sharply
The prevalence of significant liver disease associated with heavy alcohol use has increased over the past two decades despite no change in the average drinking rate, new US data show.
Serious liver disease is up among heavy drinkers, even without more drinking
Serious liver disease is becoming more common among Americans who drink heavily, according to a new study from Keck Medicine ...
Fatty liver symptoms to watch before it turns cancerous: Who’s most at risk and what lifestyle changes can help
Fatty liver disease, now medically known as MASLD, is becoming more common, especially among people who are overweight, ...
Altimmune Gears Up to Report Q2 Earnings: Here's What to Expect
ALT readies Q2 report as investors await fresh updates on pemvidutide program in obesity and liver disease studies.
Can fatty liver increase cancer risk? Know the signs and how to prevent it
Fatty liver disease, now termed MASLD, is increasingly prevalent, particularly among those with weight issues, diabetes, or ...
Gastroenterology Advisor3d
Travel Distance to LT Center May Not Affect Waitlist Mortality, Receipt of LT
Geographic distance is not associated with affecting liver transplant waitlist mortality or receipt of liver transplant.
Fatty liver: What diseases this liver condition can trigger
Fat accumulation in the liver, common in both non-drinkers (NAFLD, now MASLD) and those who consume alcohol (AFLD), may ...
Sagimet gains as Canaccord Genuity starts with Buy on potential against MASH
Sagimet Biosciences (NASDAQ:SGMT) stock rises as Canaccord Genuity endorses the company's liver drug denifanstat as it launches coverage with a Buy. Read more here.
Oncoustics Announces Initiation Of FDA-Supervised Study Of The Onx Liver Assessment Solution At Multiple Clinical Sites
Oncoustics Oncoustics initiates FDA study of the OnX Liver Assessment Solution at clinical sites across the US and Canada marking a milesto ...
Madrigal Pharmaceuticals Secures $500M Credit Facility
Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.
Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH
Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.